Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-25 @ 2:32 AM
NCT ID:
NCT00659334
Eligibility Criteria:
Inclusion Criteria:
* Brain tumor or CNS inflammatory lesion including stroke or MS
* 5 yrs old or older
* Able to undergo MRI without general anesthesia
* Agree to be followed for 1 month following infusion of Combidex
* Sign a written informed consent
* If female and of child-bearing potential, be postmenopausal, sterile, or be on birth control for 1 month prior to study
* Must have a pre-treatment MRI within 28 days before study
Exclusion Criteria:
* Clinically significant signs of uncal herniation
* Allergy to study drug, Combidex
* Hepatic insufficiency
* Stage IV or V renal insufficiency
* If female, pregnant or lactating
* Require anesthesia for MRI scanning
* Hemachromatosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
5 Years
Maximum Age:
75 Years
Study:
NCT00659334
Study Brief:
Protocol Section:
NCT00659334